04/27/2021 | Press release | Distributed by Public on 04/27/2021 04:00

VOLUNTARY ANNOUNCEMENT - BEVACIZUMAB INJECTION (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY INJECTION, ORIGINAL PROJECT CODE: HLX04) PASSED GMP COMPLIANCE ON-SITE[...]

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Download the original document